Cargando…
Avidity of IgG to SARS-CoV-2 RBD as a Prognostic Factor for the Severity of COVID-19 Reinfection
The avidity index (AI) of IgG to the RBD of SARS-CoV-2 was determined for 71 patients with a mild (outpatient) course of COVID-19, including 39 primarily and 36 secondarily reinfected, and 92 patients with a severe (hospital) course of COVID-19, including 82 primarily and 10 secondarily infected. Th...
Autores principales: | Manuylov, Victor, Burgasova, Olga, Borisova, Olga, Smetanina, Svetlana, Vasina, Daria, Grigoriev, Igor, Kudryashova, Alexandra, Semashko, Maria, Cherepovich, Bogdan, Kharchenko, Olga, Kleymenov, Denis, Mazunina, Elena, Tkachuk, Artem, Gushchin, Vladimir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8949074/ https://www.ncbi.nlm.nih.gov/pubmed/35337024 http://dx.doi.org/10.3390/v14030617 |
Ejemplares similares
-
First-In-Human Trials of GamTBvac, a Recombinant Subunit Tuberculosis Vaccine Candidate: Safety and Immunogenicity Assessment
por: Vasina, Daria V., et al.
Publicado: (2019) -
Safety and Immunogenicity of the GamTBvac, the Recombinant Subunit Tuberculosis Vaccine Candidate: A Phase II, Multi-Center, Double-Blind, Randomized, Placebo-Controlled Study
por: Tkachuk, Artem P., et al.
Publicado: (2020) -
A Deep Look Into COVID-19 Severity Through Dynamic Changes in Blood Cytokine Levels
por: Kleymenov, Denis A., et al.
Publicado: (2021) -
Contamination of Hospital Surfaces with Bacterial Pathogens under the Current COVID-19 Outbreak
por: Pochtovyi, Andrei A., et al.
Publicado: (2021) -
The Value of Rapid Antigen Tests for Identifying Carriers of Viable SARS-CoV-2
por: Shidlovskaya, Elena V., et al.
Publicado: (2021)